TCL Archive Final NIH ethics rules retain consulting ban, but limit divesture requirement to senior employees. September 9, 2005
TCL Archive IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes January 31, 2014
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49 March 22, 2002
